Search hospitals > Colorado > Aurora
Veterans Affairs Medical Center - Denver
Claim this profileAurora, Colorado 80045
Global Leader in Lung Cancer
Global Leader in Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Prostate Cancer
210 reported clinical trials
30 medical researchers
Summary
Veterans Affairs Medical Center - Denver is a medical facility located in Aurora, Colorado. This center is recognized for care of Lung Cancer, Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Prostate Cancer and other specialties. Veterans Affairs Medical Center - Denver is involved with conducting 210 clinical trials across 266 conditions. There are 30 research doctors associated with this hospital, such as Jessica D. McDermott, Ehrin Armstrong, MD, Daniel Bowles, MD, and Neda Rasouli.Area of expertise
1Lung Cancer
Global LeaderStage I
Stage II
Stage III
2Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Jessica D. McDermottRocky Mountain Regional VA Medical Center5 years of reported clinical research
Studies Cancer
Studies Lung Cancer
19 reported clinical trials
32 drugs studied
Ehrin Armstrong, MDAdventist Health2 years of reported clinical research
Studies Peripheral Vascular Disease
Studies Peripheral Arterial Disease
12 reported clinical trials
18 drugs studied
Daniel Bowles, MDUniversity of Colorado Hospital2 years of reported clinical research
Studies Cancer
Studies Salivary Gland Tumors
6 reported clinical trials
11 drugs studied
Neda RasouliUniversity of Colorado Anschutz Medical Campus1 year of reported clinical research
Studies Obesity
Studies Diabetes
8 reported clinical trials
10 drugs studied
Clinical Trials running at Veterans Affairs Medical Center - Denver
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Small Cell Lung Cancer
Diabetes
Multiple Myeloma
Peripheral Arterial Disease
Parkinson's Disease
Diabetic Kidney Disease
Plasma Cell Neoplasms
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Ramucirumab + Pembrolizumab vs Chemotherapy
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment of non-small cell lung cancer that is stage IV or that has come back after a period of improvement (recurrent). Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help doctors find out if giving ramucirumab with pembrolizumab is more effective at treating patients with stage IV or recurrent non-small cell lung cancer than standard chemotherapy.
Recruiting2 awards Phase 310 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Veterans Affairs Medical Center - Denver?
Veterans Affairs Medical Center - Denver is a medical facility located in Aurora, Colorado. This center is recognized for care of Lung Cancer, Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Prostate Cancer and other specialties. Veterans Affairs Medical Center - Denver is involved with conducting 210 clinical trials across 266 conditions. There are 30 research doctors associated with this hospital, such as Jessica D. McDermott, Ehrin Armstrong, MD, Daniel Bowles, MD, and Neda Rasouli.